FRCS Paediatric Ortho — improved notes
FRCS Paediatric Ortho — visual inline notes

064. Fibrous dysplasia

visual-inline rebuild2 extracted figuresspeaker notes XML59 study lines6 Q&A

Individual slide images have been cropped from the rendered slide and inserted beside the matching note section. The full slide remains below only for layout/audit.

Clean FRCS notes with inline figures

Fibrous dysplasia

Radiographic description

Expansile lesion at metaphyseal region of left femur with cortical thinning, intramedullary with narrow transitional zone, ground glass matrix, no periosteal reaction, mild varus deformity of proximal femur

•Fibrous dysplasia with shepherd crook deformity, Ddx: bone cyst/ enchondroma (if matrix less ground glass), infection, metabolic (brown’s tumour), haematological, metastasis in older age group

History

•Age+ premorbid
•Can involve any bone
•Female
•Current sx
•1. Pain
•Stress fracture → normal healing, but abnormal remodeling (similar to OI)
•Nocturnal pain → malignant transformation
•2. Deformity
•Mono vs polyostotic
•Coxa vara – Trendelenburg gait
•Blindness – Skull involvement

Associated:

•McCune Albright syndrome
•Triad
•Polyostotic FD
•Café au lait spots with coast of Maine, stop at midline
•Hyperfunctioning endocrine – precocious puberty, hyperT4, acromegaly
•Scoliosis
•GNAS mutation
•2. Mazabraud syndrome
•Soft tissue intramuscular myxoma

Investigations

•Inflammatory markers, ALP, LDH → increase malignant transformation
•Skeletal survey to r/o polyostotic (if yes screen for syndrome), if mono-ostotic: consider biopsy for Dx
•Histology: Alphabet soup appearance: trabeculae of osteoid within fibrous stroma

Treatment:

Aim: decrease pain, prevent fracture +/- correct deformity

Counsel about natural history:

•Progression of existing lesion + appearance of new lesion
•Old lesion will not “mature”, problem of remodeling (decrease cellularity, increase collagen deposition, persistent woven bone, no compressive or tensile trabeculae, progressive deformity)
•Progressive deformity until maturity, but may progress again with maturity
•Medical
•Bisphosphonate for symptomatic polyostotic patient for pain relief, decrease fracture, partial resolution of lesion
•Denosumab – ongoing study, latest observational study in J bone min research 2021
•Surgical

Indication for OT:

•Pathological fracture
•Enlarging lesion
•Recurrent fracture, deformity
•High stress area (femoral neck)

Principle of OT:

•For polyostotic → mainly aimed at deformity correction and prevention of fracture
•For monostotic → aim to remove tumor i.e. curettage (curative)
Operative / approach image
Fig 1. Operative / approach imagetop left
Operative / approach image
Fig 2. Operative / approach imagetop centre
•Curettage, allograft (autograft will be transformed into fibrous tissue), stable fixation with titanium IM nail
•+/- osteotomy for deformity correction
•Intraop difficulty? Prepare blood as lesions can be very vascular. Choose correct implant with right NSA

What is fibrous dysplasia?

•Localized dysfunction of osteoblast to differentiate (via increase in cAMP signaling) and mature causing failure of lamella bone formation. Bone replaced with fibrous tissue.
•Caused by mutation of Ch 20q23, not inherited
•Can be mono-ostotic / polyostotic (associated with McCune Albright syndrome)
•Can cause bone deformity, problem of remodeling

Malignant chance?

•1% (osteosarcoma/ fibrosarcoma) with poor prognosis, 5-10% in polyostotic

Direct Q&A

Q1 What history should be elicited for Fibrous dysplasia?
•Age+ premorbid
•Can involve any bone
•Female
•Current sx
•1. Pain
•Stress fracture → normal healing, but abnormal remodeling (similar to OI)
•Nocturnal pain → malignant transformation
•2. Deformity
•Mono vs polyostotic
•Coxa vara – Trendelenburg gait
•Blindness – Skull involvement
Q2 What investigations are listed for Fibrous dysplasia?

Inflammatory markers, ALP, LDH → increase malignant transformation

•Skeletal survey to r/o polyostotic (if yes screen for syndrome), if mono-ostotic: consider biopsy for Dx
•Histology: Alphabet soup appearance: trabeculae of osteoid within fibrous stroma
Q3 What natural history is described for Fibrous dysplasia?

Progression of existing lesion + appearance of new lesion

•Old lesion will not “mature”, problem of remodeling (decrease cellularity, increase collagen deposition, persistent woven bone, no compressive or tensile trabeculae, progressive deformity)
•Progressive deformity until maturity, but may progress again with maturity
•Medical
•Bisphosphonate for symptomatic polyostotic patient for pain relief, decrease fracture, partial resolution of lesion
•Denosumab – ongoing study, latest observational study in J bone min research 2021

Surgical

Q4 What are the indications listed for Fibrous dysplasia?

Pathological fracture

•Enlarging lesion
•Recurrent fracture, deformity
•High stress area (femoral neck)
Q5 What is fibrous dysplasia?
•Localized dysfunction of osteoblast to differentiate (via increase in cAMP signaling) and mature causing failure of lamella bone formation. Bone replaced with fibrous tissue.
•Caused by mutation of Ch 20q23, not inherited
•Can be mono-ostotic / polyostotic (associated with McCune Albright syndrome)
•Can cause bone deformity, problem of remodeling
Q6 Malignant chance?
•1% (osteosarcoma/ fibrosarcoma) with poor prognosis, 5-10% in polyostotic

Raw speaker-note hierarchy audit

#lvlmarLindentlogicaloriginal note line
10NoneNone0Fibrous dysplasia
20NoneNone0Describe Xray:
30NoneNone0Expansile lesion at metaphyseal region of left femur with cortical thinning, intramedullary with narrow transitional zone, ground glass matrix, no periosteal reaction, mild varus deformity of proximal femur
40171450-1714501Fibrous dysplasia with shepherd crook deformity, Ddx: bone cyst/ enchondroma (if matrix less ground glass), infection, metabolic (brown’s tumour), haematological, metastasis in older age group
50000Hx:
60000Age+ premorbid
70171450-1714501Can involve any bone
80171450-1714501Female
90000Current sx
1000001. Pain
110171450-1714501Stress fracture → normal healing, but abnormal remodeling (similar to OI)
120171450-1714501Nocturnal pain → malignant transformation
1300002. Deformity
140171450-1714501Mono vs polyostotic
150171450-1714501Coxa vara – Trendelenburg gait
160171450-1714501Blindness – Skull involvement
170000Associated:
180228600-2286001McCune Albright syndrome
190228600-2286001Triad
201685800-2286002Polyostotic FD
211685800-2286002Café au lait spots with coast of Maine, stop at midline
221685800-2286002Hyperfunctioning endocrine – precocious puberty, hyperT4, acromegaly
230228600-2286001Scoliosis
240228600-2286001GNAS mutation
2500002. Mazabraud syndrome
260171450-1714501Polyostotic FD
270171450-1714501Soft tissue intramuscular myxoma
280000Ix:
290171450-1714501Inflammatory markers, ALP, LDH → increase malignant transformation
300171450-1714501Skeletal survey to r/o polyostotic (if yes screen for syndrome), if mono-ostotic: consider biopsy for Dx
310171450-1714501Histology: Alphabet soup appearance: trabeculae of osteoid within fibrous stroma
320000Treatment:
330000Aim: decrease pain, prevent fracture +/- correct deformity
340000Counsel about natural history:
350228600-2286001Progression of existing lesion + appearance of new lesion
360228600-2286001Old lesion will not “mature”, problem of remodeling (decrease cellularity, increase collagen deposition, persistent woven bone, no compressive or tensile trabeculae, progressive deformity)
370228600-2286001Progressive deformity until maturity, but may progress again with maturity
380000Medical
390000Bisphosphonate for symptomatic polyostotic patient for pain relief, decrease fracture, partial resolution of lesion
400000Denosumab – ongoing study, latest observational study in J bone min research 2021
410000Surgical
420000Indication for OT:
430171450-1714501Pathological fracture
440171450-1714501Enlarging lesion
450171450-1714501Recurrent fracture, deformity
460171450-1714501High stress area (femoral neck)
470000Principle of OT:
480171450-1714501For polyostotic → mainly aimed at deformity correction and prevention of fracture
490171450-1714501For monostotic → aim to remove tumor i.e. curettage (curative)
501628650-1714502Curettage, allograft (autograft will be transformed into fibrous tissue), stable fixation with titanium IM nail
510000+/- osteotomy for deformity correction
520000Intraop difficulty? Prepare blood as lesions can be very vascular. Choose correct implant with right NSA
530000====================================================
540000What is fibrous dysplasia?
550171450-1714501Localized dysfunction of osteoblast to differentiate (via increase in cAMP signaling) and mature causing failure of lamella bone formation. Bone replaced with fibrous tissue.
560171450-1714501Caused by mutation of Ch 20q23, not inherited
570171450-1714501Can be mono-ostotic / polyostotic (associated with McCune Albright syndrome)
580171450-1714501Can cause bone deformity, problem of remodeling
590000Malignant chance?
6000001% (osteosarcoma/ fibrosarcoma) with poor prognosis, 5-10% in polyostotic

Improved semantic hierarchy used for the study notes

#semantic levelsection?rewritten line
10Fibrous dysplasia
20yesRadiographic description
30yesExpansile lesion at metaphyseal region of left femur with cortical thinning, intramedullary with narrow transitional zone, ground glass matrix, no periosteal reaction, mild varus deformity of proximal femur
41Fibrous dysplasia with shepherd crook deformity, Ddx: bone cyst/ enchondroma (if matrix less ground glass), infection, metabolic (brown’s tumour), haematological, metastasis in older age group
50yesHistory
61Age+ premorbid
71Can involve any bone
81Female
91Current sx
1011. Pain
111Stress fracture → normal healing, but abnormal remodeling (similar to OI)
121Nocturnal pain → malignant transformation
1312. Deformity
141Mono vs polyostotic
151Coxa vara – Trendelenburg gait
161Blindness – Skull involvement
170yesAssociated:
181McCune Albright syndrome
191Triad
202Polyostotic FD
212Café au lait spots with coast of Maine, stop at midline
222Hyperfunctioning endocrine – precocious puberty, hyperT4, acromegaly
231Scoliosis
241GNAS mutation
2512. Mazabraud syndrome
261Soft tissue intramuscular myxoma
270yesInvestigations
281Inflammatory markers, ALP, LDH → increase malignant transformation
291Skeletal survey to r/o polyostotic (if yes screen for syndrome), if mono-ostotic: consider biopsy for Dx
301Histology: Alphabet soup appearance: trabeculae of osteoid within fibrous stroma
310yesTreatment:
320yesAim: decrease pain, prevent fracture +/- correct deformity
330yesCounsel about natural history:
341Progression of existing lesion + appearance of new lesion
351Old lesion will not “mature”, problem of remodeling (decrease cellularity, increase collagen deposition, persistent woven bone, no compressive or tensile trabeculae, progressive deformity)
361Progressive deformity until maturity, but may progress again with maturity
371Medical
381Bisphosphonate for symptomatic polyostotic patient for pain relief, decrease fracture, partial resolution of lesion
391Denosumab – ongoing study, latest observational study in J bone min research 2021
401Surgical
410yesIndication for OT:
421Pathological fracture
431Enlarging lesion
441Recurrent fracture, deformity
451High stress area (femoral neck)
460yesPrinciple of OT:
471For polyostotic → mainly aimed at deformity correction and prevention of fracture
481For monostotic → aim to remove tumor i.e. curettage (curative)
492Curettage, allograft (autograft will be transformed into fibrous tissue), stable fixation with titanium IM nail
501+/- osteotomy for deformity correction
511Intraop difficulty? Prepare blood as lesions can be very vascular. Choose correct implant with right NSA
520——
530yesWhat is fibrous dysplasia?
541Localized dysfunction of osteoblast to differentiate (via increase in cAMP signaling) and mature causing failure of lamella bone formation. Bone replaced with fibrous tissue.
551Caused by mutation of Ch 20q23, not inherited
561Can be mono-ostotic / polyostotic (associated with McCune Albright syndrome)
571Can cause bone deformity, problem of remodeling
580yesMalignant chance?
5911% (osteosarcoma/ fibrosarcoma) with poor prognosis, 5-10% in polyostotic